World Pharma Newsfeed
Websites advertising cholesterol-lowering drugs of poor quality
A new study published in the journal Pharmacoepidemiology & Drug Safety reveals that internet sites selling prescription...
AstraZeneca fourth quarter and full year results 2011
AstraZeneca's revenue in the fourth quarter was unchanged at CER and on an actual basis as exchange rate movements were ...
Protein structures give disease clues
Using some of the most powerful nuclear magnetic resonance equipment available, researchers at the University of Califor...
Pfizer reports fourth-quarter and full-year 2011 results
Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter and full-year 2011. Fourth-quarter 2011 revenues w...
Novartis extends commitment to help achieve final elimination of leprosy
Novartis will continue its work with the World Health Organization (WHO) toward a world free of leprosy by extending its...
Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion
Amgen (NASDAQ: AMGN) reported total revenue increased 3 percent during the fourth quarter of 2011 to $3,973 million vers...
Alzheimer's Challenge 2012: seeking new tools to help improve Alzheimer's care
Pfizer Inc. (NYSE: PFE), together with its collaborator on the Alzheimer's Immunotherapy Program (AIP), Janssen Alzheime...
Bristol-Myers Squibb delivers solid fourth quarter capping a year highlighted by new product approvals
Bristol-Myers Squibb Company (NYSE: BMY) announced solid financial results for the fourth quarter of 2011. This conclude...
Amgen to Acquire Micromet
Amgen (NASDAQ:AMGN) and Micromet, Inc. (NASDAQ:MITI) today announced that the companies have entered into a definitive m...
Novartis delivers strong underlying financial performance in 2011
Novartis' net sales rose 4% (+5% cc) to USD 14.8 billion in the fourth quarter. The strengthening of the US dollar again...
